Ophthotech is changing its name to Iveric bio as part of its transition into a gene therapy biotech. The rebranding follows a period in which Ophthotech responded to a phase 3 setback by striking deals for retinal disease gene therapies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,